Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion

Recruiting now

Conditions studied: Coronary Atheroscleroses

In brief

Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.

Key facts

Study ID

NCT06542653

Run by

The First Affiliated Hospital with Nanjing Medical University

People needed

258

Starts

2023-09-17

Expected to finish

2025-09-17

Last updated by the study team

2024-12-27

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with at least one coronary CTO lesion at our hospital in between January 2011 and December 2017

You may not qualify if…

• (1) patients with ST-segment elevation myocardial infarction (STEMI)
• (2)a history of coronary artery bypass grafting (CABG)
• (3) cardiogenic shock
• (4) malignant tumor. Patients were referred for PCI based on CTO-related symptoms or evidence of viability, or corresponding ischemia in the area of the CTO artery.

Where it is running

• The First Affiliated Hospital with Nanjing Medical University — Nanjing, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.